To register virtually for this event, please:
Click Here to Register Now!

Once your registration has been processed, you will receive a confirmation email.


Are you located nearby and interested in registering in person?
Click Here for More Information

Transplant & Cellular Therapy Symposium 2024

Saturday, November 2, 2024
10:50 a.m. - 5:00 p.m. Eastern

Roswell Park Comprehensive Cancer Center
Research Studies Center
Elm & Carlton St
Buffalo, NY 14263

This event aims to increase participants' knowledge and enhance clinical understanding of the best practices and evidence-based advances in the care of patients who are undergoing cell transplantations, through discussions around current developments, new indications and novel therapeutics. Participants will also learn about personalized approaches to managing toxicities and rare complications post-transplant.

The contents of this meeting will also highlight the future development of novel CAR T-cell therapies and how and when to include your patients in these trials for best possible outcomes.

Learning Objectives

Following the program, participants should be able to:

  • understand the management of adverse effects associated with CAR T-cell therapy.
  • understand future advancements in field and when to refer to sub specialists for CAR T-cell therapy

Target Audience

Physicians, advanced practice providers, fellows/residents/students, and other healthcare professionals.

Accreditation

AMA Roswell Park Comprehensive Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Roswell Park designates this live educational activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Speakers

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Brian Betts, MD
Hematologic Oncology

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Brenier Brentjens, MD, PhD
Hematologic Oncology

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Marco Davila, MD, PhD
Medical Oncology

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Shernan Holtan, MD
Hematologic Oncology


Guest Speakers

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Corey Cutler, MD, MPH Director, Adult Stem Cell Transplantation Program
Director of Clinical Research, Stem Cell Transplantation
Dana Farber Cancer Institute
Boston, MA

i-9vpljtz-x3_0.jpeg?itok=6OhzW_nB

Krishna Ghimire, MD Medical Oncologist
Upstate Cancer Center,
Syracuse, NY